Pfizer beats EPS estimates for the 12th quarter. Explore PFE's oncology success, cost-cutting impact, and why it's rated a ...

With that in mind, let's consider two high-yield dividend stocks worth investing in: Pfizer (NYSE: PFE) and Medical ...

Consider the company's prospects in oncology. Pfizer acquired Seagen ... obligations to grant it more financial flexibility. MPT's turnaround story is in full swing. That's why the stock has ...

A raft of company earnings from the likes of Coca-Cola, General Motors, and Pfizer will determine if ... the Canadian election , capping a dramatic turnaround. Stocks to Watch: Noble reported ...

Pharma names such as Pfizer and BASF caught investor attention ... highlights strong market participation amid improving trade prospects and easing geopolitical risks, signaling optimism for ...

Pfizer will pay China’s 3SBio $1.25 billion up front to access a cancer drug that could rival Akeso and Summit’s closely ...

Pfizer (PFE) reported mixed first quarter earnings Tuesday, as the company focuses on gaining investor interest in its near-term pipeline amid a volatile macro environment in the markets. Pfizer ...

Pfizer's CEO said tariff uncertainty is hindering the company from making big investments in the US. Albery Bourla said there could be "tremendous investments" in R&D and manufacturing in the US ...

Pfizer Inc.’s stock rose handily Tuesday after the drug manufacturer said it’s trending toward the higher end of its 2025 profit projections. Pfizer also beat analyst expectations for first ...